CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis

BACKGROUND: The choice between upfront surgery or neoadjuvant treatments (NAT) for resectable pancreatic ductal adenocarcinoma (R-PDAC) is controversial. R-PDAC with potential nodal involvement could benefit from NT. Ca (Carbohydrate antigen) 19.9 and serum albumin levels, alone or in combination, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Alessandro, La Vaccara, Vincenzo, Fiore, Michele, Farolfi, Tommaso, Ramella, Sara, Angeletti, Silvia, Coppola, Roberto, Caputo, Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190389/
https://www.ncbi.nlm.nih.gov/pubmed/34123859
http://dx.doi.org/10.3389/fonc.2021.690580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190389/
https://www.ncbi.nlm.nih.gov/pubmed/34123859
http://dx.doi.org/10.3389/fonc.2021.690580

Ejemplares similares